Therapeutic Potential of Human Breast Milk–Derived Bioactive Components in the Management of Diabetic Foot Ulcers: A Translational Review and Modeled Clinical Evaluation
Bibliographic record
Abstract
Diabetic foot ulcers (DFUs) represent one of the most challenging complications of diabetes mellitus, leading to delayed healing, recurrent infection, and lower-limb amputation if not effectively treated. Chronic inflammation, impaired angiogenesis, altered immune response, and microbial colonization collectively hinder wound repair in affected patients. Human breast milk is a complex biofluid enriched with bioactive proteins, antimicrobial peptides, growth factors, exosomes, and living immune cells. These components demonstrate regenerative and immunomodulatory potential that could theoretically support wound healing. This study synthesizes existing biochemical and clinical evidence on the wound-healing capabilities of breast milk–derived components—particularly lactoferrin, epidermal growth factor (EGF), transforming growth factor-β (TGF-β), immunoglobulin A (IgA), and milk-derived stem-cell exosomes. A mixed-methods translational framework is proposed, including a modeled clinical trial evaluating a topical wound gel formulated from purified breast-milk bioactive fractions. In the simulated clinical dataset (n=60; DFU duration >4 weeks), patients receiving topical lactoferrin/EGF gel demonstrated faster wound area reduction (58% improvement at 4 weeks) compared to standard dressing alone (32% improvement). Microbial colony counts decreased significantly in the intervention group (p<0.01). Qualitative inflammatory markers and granulation scores also improved. The findings suggest that human breast milk–derived molecules may serve as safe, biologically compatible agents to enhance wound healing processes in DFU patients. However, direct breastfeeding or consumption of raw milk by adults is not recommended due to infection and contamination risks. Instead, pharmaceutical extraction and clinical-grade formulation of bioactive compounds is advised. Further clinical trials are needed to confirm therapeutic efficacy, determine dose standardization, and assess regulatory pathways for medical-grade lactoferrin and EGF wound formulations.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.001 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".